Global Erectile Dysfunction Market 2018-2023 - Market to Reach $4.25 Billion - ResearchAndMarkets.com

DUBLIN--()--The "Erectile Dysfunction Market - Global Outlook and Forecast 2018-2023" report has been added to ResearchAndMarkets.com's offering.

According to the latest industry analysis, the size of the global erectile dysfunction market is expected to reach $4.25 billion by 2023.

This market research report offers analysis on market size and forecast, market share, industry trends, growth drivers, and vendor analysis. The study also includes insights on segmentation by therapy type (drug therapies and device therapies) and geography (APAC, Europe, Latin America, MEA, and North America).

Increasing disease awareness, growing patient willingness to seek medical assistance for disease management, and the increasing presence of favorable guidelines are driving the growth of the erectile dysfunction market. The three most popular erectile dysfunction drugs that are available in the market are ED oral drugs, Viagra, Cialis, and Levitra. The global erectile dysfunction market is also witnessing a rising demand for low-cost generic drugs, especially in the APAC countries such as Indian and China.

The study covers a detailed overview of various market growth enablers, restraints, and trends. It covers both the demand and supply sides of the market. The study also profiles and analyzes the top six leading companies and 12 other prominent companies operating in the market.

Major Vendors

  • Bayer AG
  • Eli Lilly and Company
  • VIVUS Inc.
  • Pfizer
  • Boston Scientific Corp.
  • Coloplast A/S

Prominent Players

  • Apricus Biosciences Inc.
  • Endo International Plc
  • Futura Medical
  • Premedon
  • Teva Pharmaceutical Industries Limited (Teva)
  • Zephyr Surgical Implants (ZSI)
  • Augusta Medical Systems LLC (Augusta Medical)
  • Post-T-Vac Medical
  • Bonro Medical
  • Cristalia Produtos Quimicos Farmaceuticos Ltd.
  • SK Chemicals

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Report Coverage

5 Report Assumptions & Caveats

6 Market at a Glance

7 Introduction

8 Disease Diagnosis and Treatment Guidelines

9 Pipeline Landscape

10 Marketed Products Landscape

11 Unmet needs In Erectile Dysfunction Market

12 Market Dynamics

13 Global Erectile Dysfunction Market

14 Erectile Dysfunction Market - by Therapy Type

15 Drug Therapy Market

16 Device Therapy Market

17 Erectile Dysfunction Market - Geography

18 North America: Erectile Dysfunction Market

19 Europe: Erectile Dysfunction Market

20 APAC: Erectile Dysfunction Market

21 Latin America: Erectile Dysfunction Market

22 MEA: Erectile Dysfunction Market

23 Competitive Landscape

24 Key Company Profiles

25 Other Prominent Companies

26 Report Summary

For more information about this report visit https://www.researchandmarkets.com/research/kwz4rc/global_erectile?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Sexual and Reproductive Health Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Sexual and Reproductive Health Drugs